| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/27/2010 | EP1303503B1 Aniline derivatives |
| 01/27/2010 | CN101636200A Methods for treating pompe disease |
| 01/27/2010 | CN101633650A Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 01/27/2010 | CN101633645A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN101633644A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN100585401C Detection method for orally administered formulation for reducing fat and expelling toxins |
| 01/27/2010 | CN100584854C Efficient parts of hydrangea paniculata, their preparing method and compositions and use thereof |
| 01/27/2010 | CN100584841C Andrographolide derivatives and application of the same in pharmacy |
| 01/27/2010 | CN100584831C Pyridazinyl- piperazines and their use as histamine h3 receptor |
| 01/27/2010 | CN100584819C Substituted 4-aminocyclohexanol derivatives |
| 01/27/2010 | CN100584385C Tablet and process for producing the same |
| 01/27/2010 | CN100584382C Medicinal composition containing angiotensin II receptor agonist and fibric acid compound |
| 01/27/2010 | CN100584381C Medicinal composition containing sulfourea antidiabetic medicine and vitamine B |
| 01/27/2010 | CN100584366C Externally-applied Chinese medicine diet medicine |
| 01/27/2010 | CN100584359C Medicine for treating fatness and its complication |
| 01/27/2010 | CN100584336C Medicinal compositions |
| 01/27/2010 | CN100584326C Function of stilbene oxygen acid or salt in preparing antiatheroscloresis medicament |
| 01/27/2010 | CN100584215C Health rice with stable blood sugar content after meal and its production process |
| 01/26/2010 | US7652155 Diamine derivative, production process therefor and antioxidant |
| 01/26/2010 | US7652144 Compounds as PDE IV and TNF inhibitors |
| 01/26/2010 | US7652054 Gastrointestinal disorders; cardiovascular disorders; dyspepsia;anticancer agents; antiulcer agents |
| 01/26/2010 | US7652045 Activator of peroxisome proliferator-activated receptor δ |
| 01/26/2010 | US7652021 (2S)-4,4-difluoro-1-{N-[3-(pyrimidin-2-ylamino)-1-adamantyl]glycyl}pyrrolidine-2-carbonitrile; dipeptidyl peptidase IV enzyme inhibitors; non-insulin dependent diabetes mellitus |
| 01/26/2010 | US7652019 5,6-trimethylenepyrimidin-4-one compounds |
| 01/26/2010 | US7651844 Method for screening agents capable of treating obesity |
| 01/26/2010 | CA2610818C Preparations containing pyridoxine and .alpha.-hydroxyisocaproic acid (hica) |
| 01/26/2010 | CA2469380C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/26/2010 | CA2456606C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 01/26/2010 | CA2434731C Modular infusion device and method |
| 01/26/2010 | CA2430579C Isoindolin-1-one glucokinase activators |
| 01/26/2010 | CA2426852C Formulation containing phosphate derivatives of electron transfer agents |
| 01/26/2010 | CA2403686C Substituted piperidines as melanocortin receptor agonists |
| 01/26/2010 | CA2393083C Use of hypoglycemic agent for treating impaired glucose metabolism |
| 01/26/2010 | CA2270581C Aryloxypropanolamine derivatives, method of preparation and applications thereof |
| 01/26/2010 | CA2222524C Somatostatin peptides |
| 01/26/2010 | CA2213301C Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
| 01/21/2010 | WO2010009215A1 Nicotinic acid receptor agonist compounds useful to treat metabolic syndromes |
| 01/21/2010 | WO2010009212A1 Niacin derivatives useful to treat metabolic syndromes |
| 01/21/2010 | WO2010009208A1 Bicyclic heterocycle derivatives and methods of use thereof |
| 01/21/2010 | WO2010009207A1 Bicyclic heterocycle derivatives and their use as gpcr modulators |
| 01/21/2010 | WO2010009197A1 Solid forms of (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol and methods of their use |
| 01/21/2010 | WO2010009195A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 01/21/2010 | WO2010009183A1 Pyridone and pyridazone analogues as gpr119 modulators |
| 01/21/2010 | WO2010009139A2 Imidazolyl pyrimidine inhibitor compounds |
| 01/21/2010 | WO2010008843A1 Apoptosis signal-regulating kinase 1 inhibitors |
| 01/21/2010 | WO2010008776A2 Disposable patch and reusable sensor assembly for use in medical device localization and mapping systems |
| 01/21/2010 | WO2010008739A2 Aryl gpr119 agonists and uses thereof |
| 01/21/2010 | WO2010008333A1 Large-scale process for the preparation of thylakoids |
| 01/21/2010 | WO2010008299A1 Novel sulphur containing lipids for use as food supplement or as medicament |
| 01/21/2010 | WO2010007972A1 Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 01/21/2010 | WO2010007794A1 Novel spiro compound, and pharmaceutical preparation comprising the same |
| 01/21/2010 | WO2010007318A2 Novel imidazo[1,2-a]pyrimidine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors |
| 01/21/2010 | WO2010007316A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | WO2010007250A1 D,d-muramyl dipeptides, derived compounds and use thereof for the treatment of atheromatous plaques |
| 01/21/2010 | WO2010007046A2 Organic compounds |
| 01/21/2010 | WO2010006962A1 Derivatives of triazines and uracils, their preparation and their application in human therapeutics |
| 01/21/2010 | WO2010006940A1 Tetrahydrocinnolines as 11 beta hsd1 inhibitors for diabetes |
| 01/21/2010 | WO2010006704A1 Oxazolopyrimidines as edg-1 receptor agonists |
| 01/21/2010 | WO2010006496A1 Compounds of estrogen-related receptor modulators and the uses thereof |
| 01/21/2010 | WO2009112677A3 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 01/21/2010 | US20100016938 Diagnosing, monitoring and treating inflammation |
| 01/21/2010 | US20100016557 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 01/21/2010 | US20100016425 Methods of treating an overweight or obese subject |
| 01/21/2010 | US20100016422 Solid forms of (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol and methods of their use |
| 01/21/2010 | US20100016409 Rna Nanoparticles and Nanotubes |
| 01/21/2010 | US20100016401 3-aza-bicyclo[3.1.0]hexane derivatives |
| 01/21/2010 | US20100016396 Pyrazole compound |
| 01/21/2010 | US20100016391 Isoxazoline Compounds Having MIF Antagonist Activity |
| 01/21/2010 | US20100016375 1,5-diphenyl-3-pyridinylamino-1,5-dihydropyrrolidin-2-one as cb1 receptor modulator |
| 01/21/2010 | US20100016354 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibitory activity |
| 01/21/2010 | US20100016350 Novel mch receptor antagonists |
| 01/21/2010 | US20100016332 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 01/21/2010 | US20100016328 Pterin analogs |
| 01/21/2010 | US20100016325 Tetrahydrocinnoline derivatives |
| 01/21/2010 | US20100016321 Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulator |
| 01/21/2010 | US20100016314 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv |
| 01/21/2010 | US20100016310 Methods of using aryl sulfonyl compounds effective as soluble epoxide hydrolase inhibitors |
| 01/21/2010 | US20100016304 Glucokinase activator |
| 01/21/2010 | US20100016297 Alkyl-substituted 3' compounds having 5-ht6 receptor affinity |
| 01/21/2010 | US20100016295 Preparation and Use of Biphenyl Amino Acid Derivatives for the Treatment of Obesity |
| 01/21/2010 | US20100016289 Compounds Useful as Antagonists of CCR2 |
| 01/21/2010 | US20100016280 Low Dosage Serotonin 5-HT2A Receptor Agonist To Suppress Inflammation |
| 01/21/2010 | US20100016278 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals |
| 01/21/2010 | US20100016274 Beta-lactam cannabinoid receptor modulators |
| 01/21/2010 | US20100016272 Heteroarylacrylamides and their use as pharmaceuticals |
| 01/21/2010 | US20100016269 Composition of plant sterol and phosphatidylcholine and method for producing the same |
| 01/21/2010 | US20100016259 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 01/21/2010 | US20100016240 Facilitating cells and diabetes and methods related thereto |
| 01/21/2010 | US20100016238 Peptides for Use in the Treatment of Obesity |
| 01/21/2010 | US20100016237 Novel Peptides for Use in the Treatment of Obesity |
| 01/21/2010 | US20100016233 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues |
| 01/21/2010 | US20100016216 Adiponectin and uses thereof |
| 01/21/2010 | US20100016213 Use of a diterpenoid compound for treating diabetes |
| 01/21/2010 | US20100016210 Sensotherapy |
| 01/21/2010 | US20100015262 Novel use of compounds and combinations of compounds for improving the physical appearance |
| 01/21/2010 | US20100015258 Rice Bran Extracts and Methods of Use Thereof |
| 01/21/2010 | US20100015255 Compositions and methods for treating hypercholesterolemia using ortanique peel extract |
| 01/21/2010 | US20100015224 Programmable buoyant delivery technology |
| 01/21/2010 | US20100015190 Preparation for reducing and/or preventing body fat and respective uses, in particular together with a dressing material |
| 01/21/2010 | US20100015142 Methods for the treatment of lada and other adult- onset autoimmune using immunosuppressive monoclonal antibodies with reduced toxicity |